Aarti Drugs Ltd

NSE: AARTIDRUGS · BSE: 524348 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹416.05
Market cap: ₹3,797 Cr
Revenue (annual): ₹2,565 Cr
Net profit (annual): ₹194.9 Cr
P/E (TTM): 19.9×Sector 47.4×
Promoter holding: 54.43%-0.60% QoQ
FII holding: 1.52%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 2 Earnings Call 2 Annual General Meeting 2 Other Announcement 1 Management Change 1 Employee Stock Options 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

10 Aug 2026 21:40 IST BSE

Legal & Regulatory

Aarti Drugs Legal & Regulatory

Aarti Drugs disclosed that the Supreme Court dismissed the GST Department's Special Leave Petition, effectively disposing of the tax litigation matter in the company's favor.

Value: ₹230.7 Cr

Read the filing ↗

10 Aug 2026 21:34 IST NSE

Legal & Regulatory

Aarti Drugs Legal & Regulatory

The Supreme Court dismissed the GST Department's Special Leave Petition, favoring the company. This favorable order resolves the pending tax litigation regarding GST demands.

Read the filing ↗